NTRK1 and neoplasm: Moreover, sequence analyses have so far identified TrkAIII mRNA as the only NTRK1/TrkA splice variant in tumor samples with an in-frame tyrosine kinase domain and, therefore, oncogenic tyrosine kinase potential [16,20,25,26,27,28], which reinforces this hypothesis.